Guidelines for Neuromuscular Weakness Management

Critical Thresholds for Intervention

The American College of Chest Physicians recommends initiating noninvasive ventilation (NIV) when MIP falls below -60 cm H₂O or MEP drops below 40 cm H₂O, as these values predict impending respiratory failure requiring ventilatory support 1, 2, 3

MIP < -60 cm H₂O triggers consideration for NIV initiation, indicating significant inspiratory muscle weakness that compromises the ability to maintain adequate ventilation 1, 2, 3
MEP < 40 cm H₂O triggers NIV initiation consideration, reflecting severe expiratory muscle weakness that impairs cough effectiveness and secretion clearance 1, 2, 3

Morning headaches from nocturnal hypoventilation can occur in patients with MIP -60 to -80 cm H₂O range 2
Concentration and memory difficulties due to chronic hypercapnia can occur in patients with MIP -60 to -80 cm H₂O range 2
Orthopnea and dyspnea from diaphragmatic weakness can occur in patients with MIP -60 to -80 cm H₂O range 2
Unrefreshing sleep with snoring, gasping, or witnessed apneas can occur in patients with MIP -60 to -80 cm H₂O range 2
Reduced peak cough flow (<270 L/min) leading to mucus retention can occur in patients with MEP 40-60 cm H₂O range 2, 3
Increased risk of recurrent chest infections can occur in patients with MEP 40-60 cm H₂O range 3, 5

Perform pulmonary function testing including MIP and MEP measurements at minimum every 6 months in patients with neuromuscular disease at risk of respiratory failure, adjusting frequency based on individual disease progression rate 1, 2, 3, 4, 5
Essential testing components include forced vital capacity (FVC) or slow vital capacity (SVC) 1, 5
Essential testing components include MIP and MEP or sniff nasal inspiratory pressure (SNIP) 1, 5
Essential testing components include peak cough flow (PCF) 1, 5

Consider invasive home mechanical ventilation via tracheostomy when NIV fails despite optimal settings, bulbar function worsens, frequent aspiration occurs, or insufficient cough persists despite adequate secretion management 2, 3, 5
Early discussion of goals of care, potential institutionalization needs, and caregiver burden is required when considering invasive home mechanical ventilation via tracheostomy 3, 5
Do not delay NIV initiation when MIP/MEP thresholds are met, even in asymptomatic patients with FVC <50% predicted 2, 3